To determine the importance of ACE2 and NRP1 in mediating SARS-CoV-2 entry into the three breast cancer cell lines, we silenced ACE2 and NRP1 using specific short interfering RNAs (siRNAs). The gene discussed is NRP1; the disease is breast carcinoma.